Adagen Market, introduced in 1990, emerged as the first alternative treatment for patients diagnosed with Severe Combined Immunodeficiency (SCID) who were unable to undergo bone marrow transplants. SCID is an inherited primary immunodeficiency disorder characterized by a severely weakened immune system that renders individuals susceptible to even minor infections. This condition, also known as...
Chinese
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Greek